ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1579	National Cancer Institute	Html	en	Skin Cancer Treatment (PDQ®)–Patient Version	Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common types of skin cancer. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for skin cancer.	general cancer information 0.204481 skin cancer 0.746718 treatment 0.471679 cancer treatment 0.302297 new cancer treatments 0.201272 NCI-supported cancer 0.203834 cancer cells 0.430807 cancer spreads 0.213207 body 0.317841 type 0.211396 actinic keratosis 0.536665 Cancer Information Service 0.206951 PDQ cancer information 0.297384 Mohs micrographic surgery 0.232682 clinical trial search 0.229474 nonmelanoma skin cancers 0.227999 treatment clinical trials 0.229958 National Cancer Institute 0.31726 clinical trials 0.638709 nearby lymph nodes 0.200291	cancer information summary 0.262865 clinical trial 0.388191 new treatment 0.294947 Skin Cancer Treatment 0.245684 abnormal cells 0.206059 metastatic skin cancer 0.238791 metastatic tumor 0.203344 NCI PDQ cancer 0.214553 Treatment Option Overview 0.208332 cancer clinical trials 0.26868 stage 0.23544 tumor 0.379395 lymph node 0.25053 radiation therapy 0.273121 cancer information summaries 0.204643 nonmelanoma skin cancer 0.66985 comprehensive cancer information 0.204409 basal cell carcinoma 0.71551 cancer 0.986958 information 0.320731	CLICK HERE
1607	National Cancer Institute	Html	en	Levels of Evidence for Cancer Screening and Prevention Studies (PDQ®)–Health Professional Version	Information about how to weigh the strength of the evidence obtained in cancer screening and prevention research studies.	highly selected populations 0.401378 evidence 0.991311 health problem 0.419092 ovarian cancer results 0.40408 PDQ cancer information 0.513684 preventive service 0.422639 PDQ information 0.400135 harms 0.473049 PDQ Editorial Board 0.641716 cancer information summary 0.473744 breast cancer prevention 0.40374 overall mortality reduction 0.492575 potential benefits 0.414509 level 0.4235 evidence support 0.537413 overall evidence 0.50904 NCI’s PDQ 0.403183 quality 0.384284 NCI PDQ cancer 0.45235 reduced usual activity 0.399404 mortality effect 0.425411 intervention 0.453795 health effects 0.479173 Editorial Board 0.827603	benefits 0.440799 clear determination 0.42011 all-cause mortality question 0.432333 general population 0.48479 potential harms 0.397031 conceptual confidence interval 0.402548 health important degree 0.511077 actual evidence 0.562605 specific harms 0.394046 National Cancer Institute 0.475921 magnitude 0.455969 important health effects 0.420577 reasonably certain estimate 0.435178 PDQ documents 0.402929 pdq screening 0.511986 public health 0.419028 direction 0.390004 actual health impact 0.418321 question 0.457086 indirect evidence 0.492584 disease-specific reduction 0.408785 Prevention Editorial Board 0.514271 Alternative format 0.424205 efficacy evidence 0.51812	CLICK HERE
1703	National Cancer Institute	Html	en	Tumor Grade	A fact sheet that discusses tumor grade and its role in prognosis. Explains concepts like normal cell biology and cell differentiation.	Gleason score 0.401724 NCI fact sheet 0.404685 lower grade 0.405507 tissue organization 0.400496 better prognosis 0.354968 tumor tissue 0.703634 type-specific grading systems 0.412132 tumor type 0.491464 cancer cells 0.405656 biopsied tissue 0.413701 Gleason scores 0.355221 primary brain tumors 0.42294 tumor size 0.501863 abnormal-looking cells 0.400459 Nottingham grading 0.360235 higher-grade cancer 0.364598 tumor cells 0.631844 normal cells 0.49423 nearby lymph nodes 0.408457 tumor grade 0.785451 regional lymph node 0.409603 secondary pattern 0.388809 breast tumors 0.384185 Scarff-Bloom-Richardson grading 0.361738	normal tissue structures 0.487646 primary pattern 0.353415 microscopic examination 0.353649 breast cancer 0.39308 biopsy samples 0.354483 Staging page 0.357155 microscopic appearance 0.359178 different types 0.358151 tumors 0.490957 prostate cancer 0.440387 cancer staging 0.368981 slower rate 0.360886 American Joint Committee 0.39399 tumor 0.981653 tumor grades 0.501473 common tissue pattern 0.44497 cancer 0.557882 total score 0.354108 soft tissue sarcoma 0.443518 prostate cancers 0.367392 Gleason scoring 0.35738 tumor tissue look 0.635152 cancer stage 0.457333	CLICK HERE
1806	National Cancer Institute	Html	es	Tratamiento del cáncer de estómago (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de estómago.	after d2 gastrectomy 0.313513 gastrectomía d2 0.31496 Cunningham D 0.34388 Macdonald JS 0.318723 Chemoradiotherapy after surgery 0.344328 randomised controlled 0.319618 combined modality therapy 0.360634 mejoría significativa 0.31176 Stenning SP 0.310838 intergroup trial calgb 0.31542 Postoperative adjuvant chemoradiation 0.322032 after ci 5-fu 0.317294 fase iii 0.364462 Estados Unidos 0.347269 with s-1 0.314235 randomized trial comparing 0.314288 quimiorradioterapia posoperatoria 0.360835 ensayo rtog-9904 0.324678 patients with 0.484752 adyuvante versus tasa 0.360686 supportive care 0.325372 Clinical Oncology 0.311085 Perioperative chemotherapy versus 0.334581 chemotherapy plus best 0.312401 Smalley SR 0.318682	with surgery 0.339493 Ajani JA 0.354002 or gastroesophageal junction 0.340588 ensayo swog-s0425 0.324881 Allum WH 0.311046 quimiorradioterapia adyuvante versus 0.364135 estadio ib 0.338006 gastrectomía curativa d2 0.319296 Van Cutsem E 0.313883 Benedetti J 0.318647 quimioterapia perioperatoria 0.352185 gastric carcinoma 0.325701 gastric cancer 0.935626 Clin Oncol 0.612714 or gastro-oesophageal junction 0.317111 trial comparing 0.314461 supportive care with 0.324232 Winter K 0.319459 Gastric Cancer Study 0.317632 chemotherapy versus surgery 0.338116 grupo s-1 0.317965 Okawara GS 0.319919 care with best 0.314996 quimioterapia posoperatoria 0.31518	CLICK HERE
1916	National Cancer Institute	Html	es	Tratamiento del cáncer de endometrio (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de endometrio.	estadios iva 0.30531 siguientes procedimientos 0.345561 estadio iv 0.416394 ingle.ampliar cáncer 0.337906 pequeña cantidad 0.305869 estadios ia 0.305529 rayos x 0.305673 estadio ivb 0.327117 estadio ib 0.346728 estadio ia 0.346007 estadio iva 0.326507 National Cancer Institute 0.304825 ecografía transvaginal 0.319572 estadios iiia 0.305999 áreas anormales.ampliar examen 0.309172 Instituto Nacional 0.308479 PDQ Tratamiento 0.328152 estadio iiia 0.327997	estadio iiic 0.32708 ecograma.ampliar ecografía 0.306359 Physician Data Query 0.317231 proteína llamada mTOR 0.307532 último panel 0.306492 estadio iii 0.451856 pequeña incisión 0.304896 cuello uterino 0.921387 salpingooforectomía bilateral 0.354579 revestimiento endometrial examen 0.3113 histerectomía abdominal 0.308157 cuerpo.ampliar cáncer 0.338631 útero).ampliar cáncer 0.339682 intestinos.ampliar cáncer 0.338147 útero.ampliar cáncer 0.339136 siguientes estadios 0.306306 baja densidad 0.306437	CLICK HERE
1943	National Cancer Institute	Html	es	Síndromes cardiopulmonares (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las afecciones comunes que producen síntomas en el tórax. Los síndromes cardiopulmonares que se exponen en este sumario son la disnea relacionada con el cáncer, el derrame pleural maligno, el derrame pericárdico y el síndrome de la vena cava superior.	pleural catheter 0.17861 Ripamonti C 0.130559 dificultad respiratoria 0.26023 malignant effusion 0.115362 lung cancer 0.190962 Sin embargo 0.114284 end-of-life patients with 0.119385 indwelling pleural catheter 0.162022 Dudgeon DJ 0.13043 fármacos pleurales esclerosantes 0.112004 disfunción muscular respiratoria 0.121219 Hematol Oncol Clin 0.143013 hypoxemic patients with 0.118489 patients receiving chemotherapy 0.111162 Cancer Organisation Thoracic 0.117844 antitusivos opioides 0.112496 recurrent symptomatic malignant 0.110714 patients with 0.625852 insuficiencia cardiaca 0.134239 Pain Symptom Manage 0.478956 randomized controlled 0.112081 pleural fluid 0.136904 Cancer Dyspnea Scale 0.146703 Moroni M 0.110841 Care Cancer 0.128094	pleural catheter vs 0.135869 Physiol Neurobiol 0.116436 as symptomatic treatment 0.110943 derrame maligno fracasa 0.114534 obstructiva crónica 0.135859 vías respiratorias 0.205286 tunnelled pleural catheter 0.139919 tos crónica causa 0.111919 prospective randomized 0.110614 pleural effusions with 0.149859 Intern Med 0.132242 Clin Oncol 0.11762 Med Pediatr Oncol 0.111608 Clin North Am 0.136363 Bruera E 0.203018 systematic review 0.116364 Oncol Clin North 0.140711 American Thoracic Society 0.114142 as palliative treatment 0.110799 malignant pleural effusions 0.900896 Crit Care Med 0.171232 symptomatic malignant 0.122652 alone versus 0.11566 compared with 0.110951	CLICK HERE
1950	National Cancer Institute	Html	es	Tratamiento del linfoma primario del sistema nervioso central (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma primario del sistema nervioso central.	PDQ Tratamiento 0.61533 siguientes procedimientos 0.603081 células madre 0.655295 presente sección 0.6017 cerebro.ampliar quimioterapia 0.604557 sistema nervioso central 0.993337 Physician Data Query 0.604007 vía oral 0.602155 rayos x 0.602876	cáncer.Las pruebas 0.604229 cáncer.ampliar aspiración 0.603004 líquido cefalorraquídeo 0.626647 altas dosis 0.60123 National Cancer Institute 0.600645 siguientes riesgos 0.60046 siguientes pruebas 0.60942 Instituto Nacional 0.601773	CLICK HERE
2082	National Cancer Institute	Html	en	Cancer Clusters	A fact sheet that describes what constitutes a cancer cluster and the process for reporting and investigating suspected clusters.	major risk factor 0.385962 specific environmental hazards 0.38074 rare cancer 0.409989 website uses data 0.380594 cancer trends 0.398646 individual cancer clusters 0.469731 number 0.405815 investigators 0.393508 Health Hazard Evaluation 0.380995 Disease Control 0.519415 Health Consultations page 0.381331 cancer cluster 0.895701 cancer clusters 0.841764 National Center 0.381056 ATSDR regional offices 0.380684 different geographic area 0.38274 cluster investigations 0.411002 true cancer clusters 0.482566 public health assessments 0.472612 statistically significant difference 0.384068 vinyl chloride 0.380035 specific cancer type 0.434002 primary cancer 0.413707 U.S. Census Bureau 0.37492 specific hazardous substances 0.37613	different cancer types 0.429181 state health department 0.450442 total number 0.385248 cancer cases 0.749447 health departments 0.457783 NCI analyze variations 0.380726 local health departments 0.450682 geographic area 0.518161 specific geographic area 0.389344 health surveillance programs 0.382617 people 0.378106 epidemiologic study 0.378396 agency gathers information 0.381997 statistically significant excess 0.455543 secondary cancer 0.393665 cancer 0.954313 state cancer registries 0.443891 cancer cluster—that 0.391887 Disease Registry 0.381886 specific time period 0.392616 Toxic Substances 0.380998 cancer death rates 0.436653 cancer incidence 0.401099 Cancer Mortality Maps 0.435229	CLICK HERE
3577	National Cancer Institute	Html	en	Apply for a Grant	The NCI Grants Process provides an overview of the end-to-end lifecycle of grant funding. Learn about the types of funding available and the basics for application, review, award, and on-going administration within the NCI.	additional history 0.334336 funding 0.219323 primary roles 0.363807 American public 0.328291	cancer research discoveries 0.582458 NCI grants process 0.956659 scientific research projects 0.504965	CLICK HERE
3887	National Cancer Institute	Html	en	Childhood Vascular Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood vascular tumors.	steroid-dependent infantile hemangiomas 0.300343 Arch Dermatol 0.314605 infantile hemangiomas 0.901693 significant infantile hemangiomas 0.320133 PUBMED Abstract 0.753846 phace syndrome 0.226305 infantile cutaneous hemangiomas 0.345917 superficial infantile hemangiomas 0.313373 congenital hemangioma 0.28169 infantile haemangiomas 0.234409 infantile hepatic hemangiomas 0.307672 compound infantile hemangiomas 0.306324 Severe Infantile Hemangioma 0.319287	lobular capillary hemangioma 0.22126 hemangioma endothelial cells 0.221846 Infantile hemangioma proliferation 0.38483 Mixed Infantile Hemangiomas 0.309771 vascular tumors 0.21682 Br J Dermatol 0.208054 Pediatr Dermatol 0.504488 Drolet BA 0.2263 cutaneous infantile hemangiomas 0.372661 infantile hemangioma 0.981205 human infantile hemangioma 0.349661 et al. 0.68661	CLICK HERE